CI
AVNS

Cambiar Investors’s Avanos Medical AVNS Stock Holding History

Cambiar Investors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-947,170
Closed -$27.2M – 144
2016
Q1 		$27.2M Buy
947,170
+198,099
+26% +$5.28M 0.39% 95
2015
Q4 		$25M Buy
+749,071
New +$23.3M 0.36% 94

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Cambiar Investors's AVNS Position: Q2 2016 in Review

Cambiar Investors sold out of Avanos Medical (AVNS) in Q2 2016, closing a stake of 947,170 shares — an estimated $27.2M sold.

Cambiar Investors first reported a position in AVNS in Q4 2015 and held it in 2 quarters. The position peaked at $27.2M in Q1 2016. 352 funds tracked by Wall St. Rank hold AVNS as of Q2 2016.

  • Cambiar Investors reported no remaining Avanos Medical position as of Q2 2016 after selling out during the quarter.
  • Cambiar Investors sold 947,170 Avanos Medical shares in Q2 2016, an estimated $27.2M.
  • Cambiar Investors first reported a position in Avanos Medical in Q4 2015 and held it in 2 quarters.
  • Cambiar Investors's Avanos Medical position peaked at $27.2M in Q1 2016.
  • 352 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2016.

Based on Cambiar Investors's 13F filing for Q2 2016, filed 27 Jul 2016.